These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
[X]
|
QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2012
|
|
|
|
|
OR
|
|
|
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Large Accelerated Filer
|
[ ]
|
Accelerated Filer
|
[ ]
|
|
|
Non-accelerated Filer
|
[ ]
|
Smaller Reporting Company
|
[X]
|
|
|
(Do not check if smaller reporting company)
|
||||
|
|
Page
|
|
|
|
||
|
FINANCIAL STATEMENTS.
|
3
|
|
|
|
||
|
3
|
||
|
4
|
||
|
5
|
||
|
6
|
||
|
|
||
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
11
|
|
|
|
||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
13
|
|
|
|
||
|
CONTROLS AND PROCEDURES.
|
13
|
|
|
|
||
|
|
||
|
|
||
|
RISK FACTORS.
|
13
|
|
|
|
||
|
EXHIBITS.
|
14
|
|
|
15
|
||
|
16
|
||
|
June 30, 2012
$
(unaudited)
|
December 31, 2011
$
|
|
|
ASSETS
|
||
|
|
||
|
Current Assets
|
||
|
Cash
|
123,577
|
320,178
|
|
Prepaid expenses and deposits
|
867
|
7,575
|
|
|
||
|
Total Assets
|
124,444
|
327,753
|
|
|
||
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
||
|
|
||
|
Current Liabilities
|
||
|
Accounts payable and accrued liabilities
|
13,142
|
6,509
|
|
Accounts payable and accrued liabilities – related party
|
27,096
|
12,137
|
|
Due to related parties
|
300,000
|
300,000
|
|
|
||
|
Total Current Liabilities
|
340,238
|
318,646
|
|
|
||
|
Convertible debenture, net of discount of $9,926 and $12,669, respectively
|
552,832
|
487,331
|
|
|
||
|
Total Liabilities
|
893,070
|
805,977
|
|
|
||
|
Stockholders’ Equity (Deficit)
|
||
|
|
||
|
Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: nil preferred shares
|
–
|
–
|
|
|
||
|
Class A Preferred Stock
Authorized: 25,000,000 preferred shares, with a par value of $0.001 per share
Issued and outstanding: 7,500,000 preferred shares, respectively
|
7,500
|
7,500
|
|
|
||
|
Common Stock
Authorized: 2,000,000,000 common shares, with a par value of $0.001 per share
Issued and outstanding: 347,380,000 common shares, respectively
|
347,380
|
347,380
|
|
|
||
|
Additional paid-in capital
|
(345,427)
|
(345,427)
|
|
|
||
|
Equity (Deficit) accumulated during the development stage
|
(778,079)
|
(487,677)
|
|
|
||
|
Total Stockholders’ Equity (Deficit)
|
(768,626)
|
(478,224)
|
|
|
||
|
Total Liabilities and Stockholders’ Equity (Deficit)
|
124,444
|
327,753
|
|
For the Three
Months Ended
June 30,
2012
$
|
For the Three
Months Ended
June 30,
2011
$
|
For the Six
Months Ended
June 30,
2012
$
|
For the Six
Months Ended
June 30,
2011
$
|
Accumulated from
November 3, 2008
(date of inception)
to June 30,
2012
$
|
|
|
|
|||||
|
Revenue
|
–
|
–
|
–
|
–
|
–
|
|
|
|||||
|
Operating Expenses
|
|||||
|
|
|||||
|
Consulting fees
|
103,500
|
–
|
204,000
|
20,000
|
384,500
|
|
General and administrative
|
20,636
|
1,632
|
37,603
|
2,237
|
74,690
|
|
Management fees
|
–
|
7,500
|
–
|
15,000
|
43,727
|
|
Professional fees
|
12,289
|
11,000
|
20,789
|
26,000
|
125,395
|
|
Transfer agent fees
|
101
|
1,100
|
101
|
1,618
|
18,039
|
|
|
|||||
|
Total Operating Expenses
|
136,526
|
21,232
|
262,493
|
64,855
|
646,351
|
|
|
|||||
|
Income (Loss) Before Other Expense
|
(136,526)
|
(21,232)
|
(262,493)
|
(64,855)
|
(646,351)
|
|
|
|||||
|
Other Expense
|
|||||
|
|
|||||
|
Accretion expense
|
2,758
|
–
|
5,501
|
–
|
9,632
|
|
Gain on settlement of debt
|
–
|
–
|
–
|
–
|
(24,552)
|
|
Impairment of intangible assets
|
–
|
–
|
–
|
–
|
92,538
|
|
Interest expense
|
11,218
|
3,519
|
22,408
|
7,038
|
54,110
|
|
|
|||||
|
Total Other Expenses
|
13,976
|
3,519
|
27,909
|
7,038
|
131,728
|
|
|
|||||
|
Net Income (Loss) for the Period
|
150,502
|
24,751
|
290,402
|
71,893
|
778,079
|
|
|
|||||
|
Net Income (Loss) Per Share, Basic and Diluted
|
–
|
–
|
–
|
–
|
|
|
|
|||||
|
Weighted Average Shares Outstanding
|
347,380,000
|
538,200,000
|
347,380,000
|
538,200,000
|
|
For the Six
Months Ended
June 30,
2012
$
|
For the Six
Months Ended
June 30,
2011
$
|
Accumulated from
November 3, 2008
(date of inception)
to June 30,
2012
$
|
|
|
Operating Activities
|
|||
|
|
|||
|
Net income (loss) for the period
|
(290,402)
|
(71,893)
|
(778,079)
|
|
|
|||
|
Adjustment to reconcile net loss to cash used in operating activities:
|
|||
|
Accretion expense
|
5,501
|
–
|
9,632
|
|
Gain on settlement of debt
|
–
|
–
|
(24,552)
|
|
Impairment of intangible asset
|
–
|
–
|
92,538
|
|
Stock-based compensation
|
–
|
–
|
2,227
|
|
Shares issued for management fees
|
–
|
–
|
7,000
|
|
|
|||
|
Changes in operating assets and liabilities:
|
|||
|
Prepaid expense and deposits
|
6,708
|
–
|
(867)
|
|
Accounts payable and accrued liabilities
|
6,633
|
21,738
|
40,694
|
|
Accounts payable and accrued liabilities - related
|
14,959
|
–
|
27,096
|
|
Due to related parties
|
–
|
10,000
|
11,965
|
|
|
|||
|
Net Cash Provided (Used) in Operating Activities
|
(256,601)
|
(40,155)
|
(612,346)
|
|
|
|||
|
Investing Activities
|
|||
|
Acquisition of intangible assets
|
–
|
–
|
10,000
|
|
|
|||
|
Net Cash Provided (Used) by Investing Activities
|
–
|
–
|
(10,000)
|
|
|
|||
|
Financing activities
|
|||
|
Proceeds from convertible loan payable
|
60,000
|
10,000
|
709,600
|
|
(Repayment) of loan payable
|
–
|
–
|
(149,449)
|
|
Proceeds from related parties
|
–
|
–
|
2,649
|
|
(Repayment) to related parties
|
–
|
–
|
(25,000)
|
|
Capital contribution
|
–
|
–
|
200,600
|
|
Proceeds from the issuance of common stock
|
–
|
–
|
7,523
|
|
|
|||
|
Net Cash Provided by Financing Activities
|
60,000
|
10,000
|
745,923
|
|
|
|||
|
Increase (decrease) in Cash
|
(196,601)
|
(30,155)
|
123,577
|
|
|
|||
|
Cash, Beginning of Period
|
320,178
|
33,034
|
–
|
|
|
|||
|
Cash, End of Period
|
123,577
|
2,879
|
123,577
|
|
|
|||
|
Supplemental Disclosures
|
|||
|
Interest paid
|
–
|
–
|
–
|
|
Income tax paid
|
–
|
–
|
–
|
|
|
|||
|
Non-cash investing and financing activities
|
|||
|
Forgiveness of related party debt
|
–
|
–
|
2,649
|
|
Issuance of common shares for acquisition of assets
|
–
|
–
|
250,000
|
|
Issuance of preferred shares for acquisition of assets
|
–
|
–
|
7,500
|
|
Issuance of note payable for acquisition of assets
|
–
|
–
|
325,000
|
|
Fair Value Measurements Using
|
||||
|
Quoted prices in active
markets for identical
instruments
(Level 1)
$
|
Significant other
observable inputs
(Level 2)
$
|
Significant
unobservable inputs
(Level 3)
$
|
Balance,
June 30, 2012
$
|
|
|
Convertible debenture
|
–
|
–
|
552,832
|
552,832
|
|
|
June 30,
2012
$
|
December 31,
2011
$
|
|
Current Assets
|
124,444
|
327,753
|
|
Current Liabilities
|
340,238
|
318,646
|
|
Working Capital (Deficit)
|
(215,794)
|
9,107
|
|
|
June 30,
2012
$
|
June 30,
2011
$
|
|
Cash Flows from (used in) Operating Activities
|
(256,601)
|
(40,155)
|
|
Cash Flows from (used in) Financing Activities
|
60,000
|
10,000
|
|
Net Increase (decrease) in Cash During Period
|
(196,601)
|
(30,155)
|
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
|
HDS INTERNATIONAL CORP.
|
||
|
(the “Registrant”)
|
||
|
BY:
|
TASSOS RECACHINAS
|
|
|
Tassos Recachinas
|
||
|
President
|
||
|
Exhibit
|
Incorporated by reference
|
Filed
|
|||
|
Number
|
Description of Exhibit
|
Form
|
Date
|
Number
|
herewith
|
|
3.1
|
Articles of Incorporation.
|
S-1
|
3/24/09
|
3.1
|
|
|
3.2
|
Bylaws.
|
S-1
|
3/24/09
|
3.2
|
|
|
3.3
|
Amended and Restated Articles of Incorporation.
|
8-K
|
6/14/11
|
3.1a
|
|
|
3.4
|
Amended and Restated Articles of Incorporation.
|
8-K
|
8/17/11
|
3.1
|
|
|
10.1
|
Management Agreement between the Company and Mr. Mark Simon dated March 23, 2010.
|
10-K
|
4/07/10
|
10.1
|
|
|
10.2
|
Promissory Note issued to Newton Management Ltd. dated September 28, 2010.
|
8-K
|
10/08/10
|
10.1
|
|
|
10.3
|
Amended Management Agreement between the Company and Mr. Mark Simon dated October 1, 2010.
|
8-K
|
11/10/10
|
10.1
|
|
|
10.4
|
Investors Relations Services Agreement with Blue Chip IR dated October 1, 2010.
|
10-Q
|
11/15/10
|
10.3
|
|
|
10.5
|
Share Exchange Agreement with AmeriSure Pharmaceuticals LLC dated May 13, 2011.
|
8-K
|
5/16/11
|
10.1
|
|
|
10.6
|
Promissory Note to Amerisure Pharmaceuticals, LLC dated June 20, 2011.
|
8-K
|
6/29/11
|
10.1
|
|
|
10.7
|
Promissory Note to Serik Enterprises, Inc.
|
8-K
|
8/12/11
|
10.1
|
|
|
10.8
|
Settlement Agreement with Vail International Ltd.
|
8-K
|
8/12/11
|
10.2
|
|
|
10.9
|
Settlement Agreement with Newton Management Ltd.
|
8-K
|
8/12/11
|
10.3
|
|
|
10.10
|
Settlement Agreement with Mark Simon.
|
8-K
|
8/12/11
|
10.4
|
|
|
10.11
|
Settlement Agreement with Carrillo Huettel, LLC.
|
8-K
|
8/12/11
|
10.5
|
|
|
10.12
|
Asset Acquisition Agreement.
|
8-K
|
8/17/11
|
10.1
|
|
|
10.13
|
Promissory Note with Hillwinds Ocean Energy, LLC.
|
8-K
|
8/17/11
|
10.2
|
|
|
10.14
|
Settlement Agreement and General Mutual Release with Serik Enterprises, Inc.
|
10-Q
|
11/21/11
|
10.14
|
|
|
10.15
|
Draw Down Convertible Promissory Note.
|
10-Q
|
11/21/11
|
10.15
|
|
|
10.16
|
Intellectual Property License Agreement with Hillwinds Energy Development Corporation.
|
10-K
|
4/16/12
|
10.1
|
|
|
14.1
|
Code of Ethics.
|
10-K
|
3/29/11
|
||
|
31.1
|
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
32.1
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
X
|
|||
|
101.INS
|
XBRL Instance Document.
|
X
|
|||
|
101.SCH
|
XBRL Taxonomy Extension – Schema.
|
X
|
|||
|
101.CAL
|
XBRL Taxonomy Extension – Calculations.
|
X
|
|||
|
101.LAB
|
XBRL Taxonomy Extension – Labels.
|
X
|
|||
|
101.PRE
|
XBRL Taxonomy Extension – Presentation.
|
X
|
|||
|
101.DEF
|
XBRL Taxonomy Extension – Definition.
|
X
|
|||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|